Cedars-Sinai Cancer at Cedars-Sinai Medical Center — Los Angeles, California

Cedars-Sinai Cancer at Cedars-Sinai Medical Center is a clinical research site located in Los Angeles, California, United States 90048.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Cedars-Sinai Cancer at Cedars-Sinai Medical Center has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Endometrial Cancer.

Sponsors: Pfizer, Gilead Sciences, Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cedars-Sinai Cancer at Cedars-Sinai Medical Center?

Cedars-Sinai Cancer at Cedars-Sinai Medical Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cedars-Sinai Cancer at Cedars-Sinai Medical Center conducted?

Cedars-Sinai Cancer at Cedars-Sinai Medical Center has 4 clinical trials on record, with 4 currently active. Their work covers Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Endometrial Cancer.

Is Cedars-Sinai Cancer at Cedars-Sinai Medical Center accredited by Crixeo Health?

Yes — Cedars-Sinai Cancer at Cedars-Sinai Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cedars-Sinai Cancer at Cedars-Sinai Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.